Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
CALL
Clorox
CLX
$9.92B
| $4.18M | ﹤0.01% |
31,000
+4,800
| +18% | +$622K |
2013 Q2
15 quarters
|
|
2077
PUT
Jazz Pharmaceuticals
JAZZ
$15.3B
| $4.18M | ﹤0.01% |
28,800
-1,400
| -5% | -$182K |
2013 Q2
15 quarters
|
|
2078
CALL
DexCom
DXCM
$32.8B
| $4.18M | ﹤0.01% |
197,200
+123,600
| +168% | +$2.41M |
2013 Q2
15 quarters
|
|
2079
PUT
TripAdvisor
TRIP
$1.03B
| $4.17M | ﹤0.01% |
96,700
-75,100
| -44% | -$3.56M |
2013 Q2
15 quarters
|
|
2080
PUT
Rockwell Automation
ROK
$50.5B
| $4.17M | ﹤0.01% |
26,800
-12,900
| -32% | -$1.93M |
2013 Q2
15 quarters
|
|
2081
PUT
KB Home
KBH
$2.74B
| $4.17M | ﹤0.01% |
209,800
-158,000
| -43% | -$2.76M |
2013 Q2
15 quarters
|
|
2082
Open Text
OTEX
$5.45B
| $4.17M | ﹤0.01% |
122,464
-669,398
| -85% | -$22.3M |
2013 Q2
15 quarters
|
|
2083
CALL
Labcorp
LH
$25B
| $4.16M | ﹤0.01% |
33,756
-25,259
| -43% | -$2.99M |
2013 Q2
15 quarters
|
|
2084
CALL
Bread Financial
BFH
$3.8B
| $4.16M | ﹤0.01% |
20,925
-877
| -4% | -$166K |
2013 Q2
15 quarters
|
|
2085
CALL
Direxion Daily Energy Bull 2X ETF
ERX
$247M
| $4.16M | ﹤0.01% |
13,110
-1,510
| -10% | -$530K |
2016 Q3
2 quarters
|
|
2086
Morningstar
MORN
$7.1B
| $4.15M | ﹤0.01% |
52,823
-8,452
| -14% | -$657K |
2013 Q2
15 quarters
|
|
|
HZNP
2087
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.15M | ﹤0.01% |
280,901
-114,008
| -29% | -$1.85M |
2014 Q3
10 quarters
|
|
|
KSU
2088
PUT
DELISTED
Kansas City Southern
KSU
| $4.15M | ﹤0.01% |
48,400
-48,900
| -50% | -$4.19M |
2013 Q2
15 quarters
|
|
2089
Genesco
GCO
$386M
| $4.15M | ﹤0.01% |
74,807
+70,334
| +1,572% | +$4.19M |
2016 Q4
1 quarter
|
|
|
SHPG
2090
PUT
DELISTED
Shire pic
SHPG
| $4.15M | ﹤0.01% |
23,800
-20,100
| -46% | -$3.51M |
2016 Q2
3 quarters
|
|
2091
PUT
Paychex
PAYX
$35.5B
| $4.14M | ﹤0.01% |
70,300
+5,100
| +8% | +$310K |
2013 Q2
15 quarters
|
|
2092
HSBC
HSBC
$331B
| $4.13M | ﹤0.01% |
112,126
-61,290
| -35% | -$2.3M |
2016 Q4
1 quarter
|
|
|
WP
2093
DELISTED
Worldpay, Inc.
WP
| $4.12M | ﹤0.01% |
+64,319
| New | +$4.09M |
2017 Q1
0 quarters
|
|
2094
Vanguard Total Bond Market
BND
$158B
| $4.12M | ﹤0.01% |
+50,813
| New | +$4.11M |
2017 Q1
0 quarters
|
|
2095
Vanguard S&P 500 ETF
VOO
$1.06T
| $4.12M | ﹤0.01% |
+19,033
| New | +$4.06M |
2017 Q1
0 quarters
|
|
2096
CALL
HF Sinclair
DINO
$20.5B
| $4.12M | ﹤0.01% |
145,200
+47,000
| +48% | +$1.37M |
2013 Q2
15 quarters
|
|
2097
CALL
Helmerich & Payne
HP
$4.01B
| $4.11M | ﹤0.01% |
61,800
+12,000
| +24% | +$854K |
2013 Q2
15 quarters
|
|
2098
CALL
Sinclair Inc
SBGI
$914M
| $4.11M | ﹤0.01% |
101,400
+39,800
| +65% | +$1.47M |
2013 Q2
15 quarters
|
|
2099
PUT
ArcelorMittal
MT
$48.7B
| $4.11M | ﹤0.01% |
163,933
-292,600
| -64% | -$7.4M |
2016 Q2
3 quarters
|
|
|
XLRN
2100
DELISTED
Acceleron Pharma
XLRN
| $4.1M | ﹤0.01% |
155,071
-33,607
| -18% | -$886K |
2014 Q2
11 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.